Michael H. Goldstein is President, Ophthalmology & CMO of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 313,335 shares of OCUL, which is worth approximately $2.14 Million. The most recent transaction as insider was on Feb 03, 2022, when has been sold 63,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 313K
0% 3M change
0% 12M change
Total Value Held $2.14 Million

Michael H. Goldstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2022
BUY
Grant, award, or other acquisition
-
63,333 Added 16.81%
313,335 Common Stock
MHG

Michael H. Goldstein

President, Ophthalmology & CMO
Bedford,, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL